J. Stewart

发表

Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy.

W. C. Stewart, Angi L. Jackson, J. Stewart, 2002, Acta ophthalmologica Scandinavica.

Survey of practice-related stress among United States and European ophthalmologists

W. C. Stewart, L. A. Nelson, Michelle P. Adams, 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany.

U. Thelen, W. C. Stewart, Michael S. Kristoffersen, 2013, International journal of ophthalmology.

Corneal thickness after refractive surgery.

W. C. Stewart, J. Jenkins, J. Stewart, 2005, Ophthalmology.

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.

W. C. Stewart, A. Kolker, J. Leech, 2003, American journal of ophthalmology.

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.

W. C. Stewart, E. Sharpe, K. T. Holmes, 1999, American journal of ophthalmology.

Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.

D. Apple, K. Solomon, S. Whiteside, 1997, Archives of ophthalmology.

Glaucoma clinical trial design: A review of the literature

W. C. Stewart, L. A. Nelson, J. Stewart, 2014, Perspectives in clinical research.

Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.

P. Kóthy, I. Janulevicienė, G. Holló, 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension

W. C. Stewart, J. Stewart, L. Peplinski, 2009, Clinical ophthalmology.

Corneal Punctate Staining With Latanoprost, Bimatoprost, and Travoprost in Healthy Subjects

W. C. Stewart, J. Jenkins, Angi L. Jackson, 2003, Journal of glaucoma.

Does Religious Adherence Help Diabetic Patients' Well-Being?

W. C. Stewart, L. A. Nelson, D. Dehning, 2013 .

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy

W. C. Stewart, J. Peace, J. Stewart, 2008, Clinical ophthalmology.

The Source and Impact of Specific Parameters that Enhance Well-Being in Daily Life

W. C. Stewart, L. A. Nelson, L. Jones, 2016, Journal of Religion and Health.

Efficacy and Safety of Timolol Solution Once Daily versus Timolol Gel in Treating Elevated Intraocular Pressure

W. C. Stewart, J. Stewart, T. Leland, 1998, Journal of glaucoma.

Experimental alveolar lipo‐proteinosis following the inhalation of silica

J. A. Stewart, N. Wright, A. Heppleston, 1970, The Journal of pathology.

Incidence of Conjunctival Exposure following Drainage Device Implantation in Patients with Glaucoma

W. C. Stewart, M. Fsadni, Caroline J Kristoffersen, 2010, European journal of ophthalmology.

Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma

J. A. Stewart, W. C. Stewart, L. A. Nelson, 2011, Current eye research.

Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications

Robert D Fechtner, D. Budenz, W. C. Stewart, 2010, Cornea.

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

W. C. Stewart, E. Sharpe, K. T. Holmes, 2000, American journal of ophthalmology.

Intraoperative intracameral carbachol in phacoemulsification and posterior chamber lens implantation.

H. H. Hunt, W. C. Stewart, K. Solomon, 1998, American journal of ophthalmology.

Predictive value of the efficacy of glaucoma medications in animal models: preclinical to regulatory studies

W. C. Stewart, G. Magrath, L. A. Nelson, 2010, British Journal of Ophthalmology.

Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines.

J. A. Stewart, B. Kruft, A. Konstas, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open‐angle glaucoma or ocular hypertension

W. C. Stewart, B. Kaluzny, J. Kałużny, 2008, Acta ophthalmologica.

Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects

W. C. Stewart, J. Jenkins, K. T. Holmes, 2004, Eye.

Intraocular pressure reduction in normal-tension glaucoma patients in South Korea

J. A. Stewart, C. Kim, G. Seong, 2011, International Ophthalmology.

Description of Ophthalmic Pharmaceutical and Device Start-Up Companies

B. Kruft, W. C. Stewart, L. A. Nelson, 2015, Ophthalmic Research.

24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

A. Konstas, W. C. Stewart, N. Georgiadis, 2005, Ophthalmology.

Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension

J. A. Stewart, W. C. Stewart, E. Sharpe, 2003, British Journal of Ophthalmology.

Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.

W. C. Stewart, Naveed B K Shams, J. Stewart, 2002, Acta ophthalmologica Scandinavica.

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.

W. C. Stewart, K. Latham, D. Day, 2001, American journal of ophthalmology.

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.

G. Schwartz, W. C. Stewart, K. T. Holmes, 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.

J. A. Stewart, W. C. Stewart, L. A. Nelson, 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Safety and Efficacy of Bimatoprost 0.03% versus Timolol Maleate 0.5%/Dorzolamide 2% Fixed Combination

W. C. Stewart, J. Jenkins, E. Sharpe, 2005, European journal of ophthalmology.

The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients

M. Atkinson, W. C. Stewart, E. Sharpe, 2004, Eye.

Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.

Harris A. Jaffee, J. A. Stewart, A. Konstas, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Cost-effectiveness of treating ocular hypertension.

W. C. Stewart, M. Mychaskiw, Q. Nasser, 2008, Ophthalmology.

The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.

J. A. Stewart, W. C. Stewart, R. Whitaker, 1998, Ophthalmic surgery and lasers.

Ophthalmologist Attitudes regarding Fixed Combination Treatment for Glaucoma in the European Union

B. Kruft, W. C. Stewart, L. A. Nelson, 2009, European journal of ophthalmology.

Physician Attitudes regarding Prostaglandin Treatment for Glaucoma in the United States and Europe

B. Kruft, L. A. Nelson, J. Stewart, 2007, European journal of ophthalmology.

Ep idem iology of glaucoma in cen tra l Eth iop ia

J. A. Stewart, B. Kruft, J. Stewart, 2008 .

Adverse event reporting.

B. Kruft, W. C. Stewart, L. A. Nelson, 2007, Ophthalmology.

The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily.

W. C. Stewart, T. Mundorf, C. Sine, 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Is There Any Difference in Target Intraocular Pressure for Exfoliative Glaucoma Patients with Cardiovascular Disease History?

J. A. Stewart, M. Irkec, P. Kóthy, 2010, European journal of ophthalmology.

Association of strength of religious adherence to quality of life measures.

W. C. Stewart, L. A. Nelson, J. Stewart, 2013, Complementary therapies in clinical practice.

A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

M. Atkinson, W. C. Stewart, J. Lohs, 2003, Health and quality of life outcomes.

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.

J. A. Stewart, Chang Sik Kim, Yong Yeon Kim, 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension

J. A. Stewart, M. Irkec, G. Holló, 2009, Eye.

Long-Term Progression at Individual Mean Intraocular Pressure Levels in Primary Open-Angle and Exfoliative Glaucoma

J. A. Stewart, G. Holló, A. Konstas, 2008, European journal of ophthalmology.

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

J. A. Stewart, N. Pfeiffer, W. C. Stewart, 2010, Clinical ophthalmology.

Meta-analysis of Timolol on Diurnal and Nighttime Intraocular Pressure and Blood Pressure

W. C. Stewart, Caroline J Kristoffersen, A. Doyle, 2010, European journal of ophthalmology.

Comparison of Daytime Efficacy and Safety of Dorzolamide/Timolol Maleate Fixed Combination versus Latanoprost

W. C. Stewart, J. Stewart, A. Ahmad, 2008, European journal of ophthalmology.

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%

A. Konstas, W. C. Stewart, V. Kozobolis, 2004, Eye.

Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open‐angle and exfoliative glaucoma

A. Konstas, W. C. Stewart, A. Vakalis, 2009, Acta ophthalmologica.

Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials

W. C. Stewart, L. A. Nelson, J. Stewart, 2012, British Journal of Ophthalmology.

The Effects of Unoprostone Isopropyl 0.12% and Timolol Maleate 0.5% on Diurnal Intraocular Pressure

W. C. Stewart, B. Kapik, J. Stewart, 1998, Journal of glaucoma.

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.

J. A. Stewart, W. C. Stewart, E. Sharpe, 2001, American journal of ophthalmology.

Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.

J. A. Stewart, M. Krajewska, W. C. Stewart, 2003, Acta ophthalmologica Scandinavica.

Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy

W. C. Stewart, J. Jenkins, E. Sharpe, 2004, Eye.

Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.

W. C. Stewart, E. Sharpe, D. Day, 2003, Acta ophthalmologica Scandinavica.

Dorzolamide/Timolol Fixed Combination Versus Latanoprost/Timolol Fixed Combination in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

W. C. Stewart, L. A. Nelson, B. Cvenkel, 2008, Current Eye Research.

Intraocular Pressure-lowering Efficacy of Brinzolamide When Added to Travoprost/Timolol Fixed Combination as Adjunctive Therapy

J. Crowston, I. Goldberg, W. C. Stewart, 2012, Journal of glaucoma.

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model

W. C. Stewart, M. Mychaskiw, J. Stewart, 2009, Eye.

Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma.

J. A. Stewart, W. C. Stewart, J. Jenkins, 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression

J. A. Stewart, W. C. Stewart, S. Diafas, 2007, Therapeutics and clinical risk management.

Long-Term Benefit of Reduced Intraocular Pressure in Primary Open-Angle Glaucoma Patients in Ethiopia

W. C. Stewart, Michael S. Kristoffersen, Caroline J Kristoffersen, 2010, European journal of ophthalmology.

Challenges facing ophthalmic start‐up companies in developing new devices or medicines

B. Kruft, W. C. Stewart, L. A. Nelson, 2013, Acta ophthalmologica.

Techniques to Reduce the Placebo Effect in Glaucoma Clinical Trials

W. C. Stewart, L. A. Nelson, J. Stewart, 2015, Ophthalmic Research.

Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension

W. C. Stewart, J. Jenkins, E. Sharpe, 2005, Eye.

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients

J. A. Stewart, W. C. Stewart, M. Miyashiro, 2010, Clinical ophthalmology.

The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.

W. C. Stewart, J. Jenkins, D. Day, 2004, Acta ophthalmologica Scandinavica.

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

P. Schacknow, W. C. Stewart, E. Sharpe, 2003, American journal of ophthalmology.

Review of the Influence of Pigment Dispersion and Exfoliation Glaucoma Diagnosis on Intraocular Pressure in Clinical Trials Evaluating Primary Open-angle Glaucoma and Ocular Hypertension

D. DeMill, W. C. Stewart, B. Wirostko, 2013, Journal of glaucoma.

Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy

W. C. Stewart, L. A. Nelson, E. Sharpe, 2008, Acta ophthalmologica.

Review of the impact of presbyopia on quality of life in the developing and developed world

William R. Burns, W. C. Stewart, L. A. Nelson, 2014, Acta ophthalmologica.

Average versus Highest Intraocular Pressure Analyses in Glaucoma Clinical Trials

D. DeMill, W. C. Stewart, B. Wirostko, 2012, Ophthalmic Research.

Energy dispersion and relaxation in propynal using laser ir/visible double resonance

G. Smith, W. A. Guillory, M. Lesiecki, 1980 .

Review of Clinical Medicine and Religious Practice

J. A. Stewart, W. C. Stewart, L. A. Nelson, 2013, Journal of Religion and Health.

Association of Strength of Religious Adherence with Attitudes regarding Glaucoma or Ocular Hypertension

W. C. Stewart, L. A. Nelson, E. Sharpe, 2010, Ophthalmic Research.

Risk factors for subject withdrawals in clinical trials evaluating glaucoma medications

W. C. Stewart, C. Demos, J. Stewart, 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

Total cholesterol and high-density lipoprotein levels as risk factors for increased intraocular pressure.

J. A. Stewart, S. Sutherland, W. C. Stewart, 1996, American journal of ophthalmology.

Risk Factors Associated with Progression in Exfoliative Glaucoma Patients

J. A. Stewart, S. Miglior, P. Kóthy, 2011, Ophthalmic Research.

Association of Strength of Community Service to Personal Wellbeing

W. C. Stewart, L. A. Nelson, J. Stewart, 2014, Community Mental Health Journal.

Efficacy and Safety of Latanoprost/Timolol Maleate Fixed Combination Verses Timolol Maleate and Brimonidine Given Twice Daily

J. A. Stewart, W. C. Stewart, E. Sharpe, 2002 .

Phase 1 / 2 Double-Masked Randomized Vehicle-Controlled Study H-1337 Ophthalmic Solution in Glaucoma and Ocular Hypertension.

G. Novack, Kengo Sumi, Y. Yoshida, 2022, Ophthalmology. Glaucoma.

The effect of stimulus duration upon the components of fluctuation in static automated perimetry

H H Hunt, H. H. Hunt, G E Pennebaker, 1992, Eye.

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate.

W. C. Stewart, K. T. Holmes, J. Leech, 2000, American journal of ophthalmology.

The Apologetic Significance of Religion and Wellness Studies

W. C. Stewart, L. A. Nelson, J. Stewart, 2017 .

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

R. Schumer, R. Ritch, D. Steinberger, 1996, Ophthalmology.

Success of ophthalmic pharmaceutical start‐up companies

B. Kruft, W. C. Stewart, L. A. Nelson, 2018, Acta ophthalmologica.

Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry

C. O'brien, J. A. Stewart, L. Rossetti, 2010, Eye.

The Effect of Early Sexual Activity on Mental Health

W. C. Stewart, L. A. Nelson, J. Stewart, 2018 .

Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.

Harris A. Jaffee, A. Konstas, W. C. Stewart, 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Health and Quality of Life Outcomes

M. Atkinson, W. C. Stewart, J. Lohs, 2003 .

Review of the Influence of Pigment Dispersion and Exfoliation Glaucoma Diagnosis on Intraocular Pressure in Clinical Trials Evaluating Primary Open-angle Glaucoma and Ocular Hypertension

D. DeMill, W. C. Stewart, B. Wirostko, 2013, Journal of glaucoma.

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients

J. Stewart, M. J. Miyashiro, William C. Stewart, 2010 .